Literature DB >> 9352309

Purinergic modulation of rat urinary bladder detrusor smooth muscle.

J A King1, H Huddart, W G Staff.   

Abstract

1. Rat detrusor muscle was responsive to both ATP and adenosine; ATP elicited an excitatory response, whereas adenosine had an inhibitory effect. 2. ATP and adenosine had an inhibitory modulatory action on responses to acetylcholine, potassium depolarization and field stimulation. 3. Quinidine inhibited the ATP response and blocked the inhibitory effect of ATP on acetylcholine, potassium-depolarization and field-stimulation responses. The effect of adenosine remained unaltered in the presence of quinidine. 4. Caffeine and theophylline blocked the adenosine inhibition of responses to field stimulation. 5. It is concluded that excitatory P2-type purinoreceptors mediated by ATP and inhibitory P1-type purinoreceptors mediated by adenosine exist in rat urinary bladder detrusor smooth muscle and that both ATP and adenosine exhibit a modulatory action on detrusor muscle agonist-induced responses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9352309     DOI: 10.1016/s0306-3623(96)00573-3

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  7 in total

1.  ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells.

Authors:  Edward C Y Wang; Jey-Myung Lee; Wily G Ruiz; Elena M Balestreire; Maximilian von Bodungen; Stacey Barrick; Debra A Cockayne; Lori A Birder; Gerard Apodaca
Journal:  J Clin Invest       Date:  2005-08-18       Impact factor: 14.808

2.  Targetable purinergic receptors P2Y12 and A2b antagonistically regulate bladder function.

Authors:  Yuan Hao; Lu Wang; Huan Chen; Warren G Hill; Simon C Robson; Mark L Zeidel; Weiqun Yu
Journal:  JCI Insight       Date:  2019-08-22

3.  PACAP-mediated ATP release from rat urothelium and regulation of PACAP/VIP and receptor mRNA in micturition pathways after cyclophosphamide (CYP)-induced cystitis.

Authors:  Beatrice M Girard; Amanda Wolf-Johnston; Karen M Braas; Lori A Birder; Victor May; Margaret A Vizzard
Journal:  J Mol Neurosci       Date:  2008-06-19       Impact factor: 3.444

Review 4.  Purinergic signalling in the urinary tract in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

Review 5.  Purinoceptors as therapeutic targets for lower urinary tract dysfunction.

Authors:  Anthony P D W Ford; Joel R Gever; Philip A Nunn; Yu Zhong; Joseph S Cefalu; Michael P Dillon; Debra A Cockayne
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

6.  Impairment of ATP hydrolysis decreases adenosine A1 receptor tonus favoring cholinergic nerve hyperactivity in the obstructed human urinary bladder.

Authors:  M Silva-Ramos; I Silva; M Faria; M T Magalhães-Cardoso; J Correia; F Ferreirinha; P Correia-de-Sá
Journal:  Purinergic Signal       Date:  2015-10-31       Impact factor: 3.765

7.  Expression and distribution of ectonucleotidases in mouse urinary bladder.

Authors:  Weiqun Yu; Simon C Robson; Warren G Hill
Journal:  PLoS One       Date:  2011-04-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.